305 related articles for article (PubMed ID: 16972375)
1. Stanford to ban drug makers' gifts to doctors, even pens.
Pollack A
N Y Times Web; 2006 Sep; ():C2. PubMed ID: 16972375
[No Abstract] [Full Text] [Related]
2. Why academic medical centers should ban drug company gifts to individuals.
Strong C
Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
[No Abstract] [Full Text] [Related]
3. In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
Harris G
N Y Times Web; 2006 Jan; ():A14. PubMed ID: 16450472
[No Abstract] [Full Text] [Related]
4. Drug reps and the academic medical center: a case for management rather than prohibition.
Huddle TS
Perspect Biol Med; 2008; 51(2):251-60. PubMed ID: 18453729
[TBL] [Abstract][Full Text] [Related]
5. Charities tied to doctors get drug industry gifts.
Abelson R
N Y Times Web; 2006 Jun; ():A1, C4. PubMed ID: 16838451
[No Abstract] [Full Text] [Related]
6. Seducing the medical profession.
N Y Times Web; 2006 Feb; ():A22. PubMed ID: 16502529
[No Abstract] [Full Text] [Related]
7. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Katz D; Caplan AL; Merz JF
Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489
[TBL] [Abstract][Full Text] [Related]
8. The pitfalls of misreading: what does "industry funding of medical education" actually say?
Spielman B
Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332
[No Abstract] [Full Text] [Related]
9. Avoiding over-deterrence in managing physicians' relationships with industry.
Stell LK
Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
[No Abstract] [Full Text] [Related]
10. Drug detailers, professionalism, and prudence.
Brody H
Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325
[No Abstract] [Full Text] [Related]
11. The AAMC exhibits the behavior it condemns.
Stossel TP
Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
[No Abstract] [Full Text] [Related]
12. The devil in the detail(ing).
Morreim H
Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
[No Abstract] [Full Text] [Related]
13. [Is it pertinent to investigate the relations between physicians and the drug industry].
Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
[TBL] [Abstract][Full Text] [Related]
14. The details are in the field.
Schwab AP
Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
[No Abstract] [Full Text] [Related]
15. Huddle gets it right, most docs don't.
Rubin PH
Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
[No Abstract] [Full Text] [Related]
16. Lunch with Lilly: who pays?
Strong C
Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
[No Abstract] [Full Text] [Related]
17. Contact with pharmaceutical representatives: where does prudence lead?
Appelbaum PS
Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
[No Abstract] [Full Text] [Related]
18. Patient care vs. corporate connections: Cleveland Clinic wants to change but won't cut ties to industry.
Abelson R; Pollack A
N Y Times Web; 2005 Jan; ():C1, C4. PubMed ID: 15682548
[No Abstract] [Full Text] [Related]
19. Pens and other pharmaceutical industry gifts.
Brody H
Am J Bioeth; 2003; 3(3):58-60. PubMed ID: 14594497
[No Abstract] [Full Text] [Related]
20. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
Berger JT
Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
